# Prospective Evaluation of 14F Thal Tube vs 28 French Chest Tube for Hemothorax and Use of Maximum Barrier Precautions

> **NCT03167723** · NA · COMPLETED · sponsor: **Wake Forest University Health Sciences** · enrollment: 193 (actual)

## Conditions studied

- Hemothorax
- Hemopneumothorax; Traumatic
- Empyema
- Chest Tube Size

## Interventions

- **DEVICE:** Chest tube placement

## Key facts

- **NCT ID:** NCT03167723
- **Lead sponsor:** Wake Forest University Health Sciences
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-05-08
- **Primary completion:** 2021-12-20
- **Final completion:** 2021-12-20
- **Target enrollment:** 193 (ACTUAL)
- **Last updated:** 2023-03-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03167723

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03167723, "Prospective Evaluation of 14F Thal Tube vs 28 French Chest Tube for Hemothorax and Use of Maximum Barrier Precautions". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03167723. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*